HIV /AIDS DEVELOPMENT IN YEAR 2103 :ZERO GOAL & TREATMENT TO ALL: NO DISCIMINATION,NO SHAME NO STIGMA : TAKE TREATMENT AND CURE IT ;INSURANCE CARE TO EVERY HIV/AIDS IN USA UNDER PEPFAR ND TREATMENT FOR EVERYBODY AND ENSURING ADHERANCE OR COMPLIANCE OF TRETENT AND MAKING HIV TO ZERO LEVEL : TO ERADICATE HIV NOT FROM USA BUT WHOLE WORLD ALONG WITH TB AND MALARIA;DOES IT WORKING NORMALLY ?

HAPPY NEW YEAR 2104 TO ALL MY FRIENDS,HIV/AIDS FRIENDS/MEMBERS OF LGBT

PROF.DRRAM ,HIV/AIDS,SEX DISEASES,SEX WEAKNESS & ABORTION SPECIALIST
profdrram@gmail.com,07838059592, DELHI –NCR,marriage & sex counseling
FOLLOW ON FACE BOOK:www.facebook.com/drramkumar
FOLLOW ON TWITTER:www.twitter.com/profdrram

HIV /AIDS treatment has markedly changed s after when the World Health Organization established the first World AIDS Day on December 1, 1988, treatment options for people living with HIV were practically nonexistent, and AIDS was almost invariably fatal. Hope was in short supply, and there seemed to be little reason for optimism. I am grateful that the world is a very different place for the 25th annual World AIDS Day.
In between whole world united to put much slogans for HIV/AIDS care as disease cannot be eradicated and it was reporteed tht death is very painful nd is the ultimate fte and widespred sex activites are really a greatt danger to world .
In US first time realised that HIV/AIDS patients are very much neglected and due to lack of education most persons discriminatte and stigmtise HIV/AIDS patients and further push them for no care and as treatment and diagnosis being very costly so often patient donot seek treatment or leave treatment.US Subsequently, in late 2011 CDC did its own analysis of HIV surveillance datasets, viral load and CD4 laboratory reports, and other published data to develop national estimates of the number of HIV-infected persons at each step of the treatment cascade. Their findings, published in CDC’s Morbidity and Mortality Weekly Report (MMWR), were similar to those of Dr. Gardner and his colleagues and can be summarized as follows:
For every 100 individuals living with HIV in the United States, it is estimated that:
80 are aware of their HIV status.
62 have been linked to HIV care.
41 stay in HIV care.
36 get antiretroviral therapy (ART).
28 are able to adhere to their treatment and sustain undetectable viral loads.
In short, CDC estimated that only 28 percent of the more than 1 million individuals in the U.S. who are living with HIV/AIDS are getting the full benefits of the treatment they need to manage their disease and keep the virus under control. Put another way, nearly 3 out of 4 people living with HIV in the U.S. have failed to successfully navigate the treatment cascade.
Therefore before 10 yrs,The President’s Emergency Plan for AIDS Relief (PEPFAR) was aanounced.After 10th yrs This Yer OBAMA hs further added to PEPFAR which now directly supports life-saving antiretroviral treatment for millions of men, women, and children worldwide. Together with the Global Fund to Fight AIDS, Tuberculosis and Malaria and partner nations, we are working toward an AIDS-free generation around the world.
Now it hs been adopted that treatment and diagnosis should be done as soon as possible and now treatment in US is not important treat every patient of world to make HIV/AIDS TO ZERO LEVEL.Now in USA from year 2014 EVERY HIV/AIDS patient will be provided INSURANCE FOR DIAGNOSIS,FULL TREATMENT AND COMPLICATION AT VERY AFFORDABLE PRICES.Here in the U.S., guided by the National HIV/AIDS Strategy, (NHAS), agencies and offices across the Department of Health and Human Services are working to strengthen HIV prevention, care and treatment efforts. As President Obama directed earlier this year when he established the HIV Care Continuum Initiative, we are accelerating efforts to increase HIV testing as well as improve access to and retention in HIV care. That way, we can better address drop-offs along the continuum of HIV care, from diagnosis to receiving optimal treatment. Fewer than half of the people living with HIV are getting the medical care they need, and only about 25 percent have achieved control over their HIV infection with medication. Such control both benefits their health and reduces the likelihood of HIV transmission.
SO TREAT ALL APTEINTS AND GIVE THEM FREE MEDICINES,CARE AND INVESTIGATION IRESPECTIVE OF THEIR NTIONALITY CASTE,CREED OR COLOR TO CURB HIV COMPLETELY.

HIV /AIDS DEVELOPMENT IN YEAR 2103 :ZERO GOAL & TREATMENT TO ALL: NO DISCRIMINATION,NO SHAME NO STIGMA : TAKE TREATMENT AND CURE IT
HAPPY NEW YEAR 2104 TO ALL MY FRIENDS,HIV/AIDS FRIENDS/MEMBERS OF LGBT
PROF.DRRAM ,HIV/AIDS,SEX DISEASES,SEX WEAKNESS & ABORTION SPECIALIST
profdrram@gmail.com,07838059592, DELHI –NCR,marriage & sex counseling
FOLLOW ON FACE BOOK:www.facebook.com/drramkumar
FOLLOW ON TWITTER:www.twitter.com/profdrram
FEW SUCCESSFUL STORIES OF HIV TREATMENT OF YEAR 2013 IS AS FOLLOWS:----
HIV research and development achieved several discoveries in 2013 - from drug therapy to unconventional and risky methods to eliminate the virus. Some of them found new things about HIV and plans to put them into trial. Here are some of notable anti-HIV results for this year to know what we can expect for 2014.
Saving Infected Cells
Two new discoveries are revealed by researchers at Dresden Technical University in Germany and Gladstone Institutes in California to save infected cells from HIV viral load. German scientists found out that there is a way to restore infected cells back to normal by cutting HIV viral load using an enzyme on the DNA of host cells. Scientists in California figured out that HIV host cells are killed by the immune system by Pyroptosis and stopping the process will prevent the body to eliminate infected cells in order to stop further spread of viral loads.
Vaccine Research
Scientists from Spain and United Kingdom are expected to begin clinical trials against HIV in the coming years. Spanish Hospital researchers announced an upcoming plan in 2014 regarding a new drug to treat the disease instead of preventing it. Experts and clinicians from five leading universities in United Kingdom aim a functional cure for HIV by starting clinical trials. It will be a combined therapy of antiretroviral drugs and two additional components to wipe viral loads completely.
Genetic and Transplant
Bone marrow transplant has been used as an unconventional method to cure or treat HIV/AIDS. Timothy Brown is the only survivor with no reoccurrence of HIV viral load after a successful transplant to treat his blood cancer. The genetic mutation called CCR5 delta 32 from his donor provided resistance against the virus which prevented HIV from killing off T cells in Brown's blood.
Scientists are looking into a solution to engineer drugs or methods to replicate such genetic mutation to allow HIV/AIDS patients to resist the viral effects. CCR5 delta32 genetic flaw will prevent HIV to attach on T cells and allows the immune system to cleanse out the entire body.
HIV just got a new strain that can put someone into AIDS stage in just five years. Since there is no cure or vaccine against the usual strains, it is going to be more dangerous if HIV mutates again and developed another dangerous strain. Hopefully, all clinical trials receive positive results and reach commercial markets next year.

HIV /AIDS CONTROL: BY HUMAN MX2 GENE-GREAT RESEARCH OF YEAR 2013

PROF.DRRAM ,HIV/AIDS,SEX DISEASES,SEX WEAKNESS & ABORTION SPECIALIST
profdrram@gmail.com,07838059592, DELHI –NCR,marriage & sex counseling
FOLLOW ON FACE BOOK:www.facebook.com/drramkumar
FOLLOW ON TWITTER:www.twitter.com/profdrram

Human body has got so many genes out of which one gene known as MX@ Gene hs been isolated and it is found that in nimal experiment this gene inhibit HIV Virus bypenetrating its envelop and proteins associated with it .

so there is role of Human MX2 gene effective in inhibiting HIV

A study published in the journal Nature identified the role of human MX2 gene in inhibiting HIV, thereby preventing the spread of the virus after entering the body. Researchers suggest that MX2 gene could be used as the new target for developing efficient, less toxic treatments involving the body’s own natural defense mechanism against the virus.